Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Gefitinib industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Nobel Ilac Sanayii Ve Ticaret
Qilu Pharmaceutical
Hetero Drugs
Celon Laboratories
Sichuan Xieli Pharmaceutical
Nishchay Pharmaceuticals
Jodas Expoim
Panacea Biotec
Natco Pharma
Dr Reddy’s Laboratories
Cadila Pharmaceuticals
AstraZeneca
United Biotech
Zuventus Healthcare
Cipla
Flagship Biotech International
Globela Pharma
By Type:
90 Tables/Box
10 Tables/Box
30 Tables/Box
By Application:
Hospital
Drug Center
Other
Clinic
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Gefitinib Market Overview 2018-2029
-
1.1 China Gefitinib Industry Development Overview
-
1.2 China Gefitinib Industry Development History
-
1.3 China Gefitinib Industry Market Size (2018-2029)
-
1.4 China Gefitinib Market Analysis by Type from Production Side
-
1.4.1 China Gefitinib Production Volume, Production Value and Growth Rate of 90 Tables/Box (2018-2029)
-
1.4.2 China Gefitinib Production Volume, Production Value and Growth Rate of 10 Tables/Box (2018-2029)
-
1.4.3 China Gefitinib Production Volume, Production Value and Growth Rate of 30 Tables/Box (2018-2029)
-
1.5 China Gefitinib Market Analysis by Application from Consumption End
-
1.5.1 China Gefitinib Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
1.5.2 China Gefitinib Sales Volume, Sales Value and Growth Rate of Drug Center (2018-2029)
-
1.5.3 China Gefitinib Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
1.5.4 China Gefitinib Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
1.6 China Gefitinib Market Analysis by Region
-
1.6.1 North China Gefitinib Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Gefitinib Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Gefitinib Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Gefitinib Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Gefitinib Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Gefitinib Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Gefitinib Market Size and Growth Rate from 2018-2029
Chapter 2 China Gefitinib Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Gefitinib Market Status and Competition at home and abroad in 2023
-
2.2.2 China Gefitinib Market Status and Competition Analysis in 2023
-
2.2.3 China Gefitinib Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Gefitinib Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Gefitinib Industry Development
Chapter 3 GefitinibIndustry Chain Analysis
-
3.1 Gefitinib Industry Chain
-
3.2 Gefitinib Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Gefitinib Market
-
3.3 Gefitinib Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Gefitinib Market
Chapter 4 China Gefitinib Market, by Type
-
4.1 China Gefitinib Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Gefitinib Total Production Volume and Growth Rate from Production Side
-
4.5 China Gefitinib Production Volume and Growth Rate, by Type
-
4.5.1 China Gefitinib Production Volume and Growth Rate of 90 Tables/Box
-
4.5.2 China Gefitinib Production Volume and Growth Rate of 10 Tables/Box
-
4.5.3 China Gefitinib Production Volume and Growth Rate of 30 Tables/Box
Chapter 5 China Gefitinib Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Gefitinib Total Market Size and Growth Rate from Consumption End
-
5.5 China Gefitinib Market Size and Growth Rate, by Application
-
5.5.1 China Gefitinib Market Size and Growth Rate of Hospital
-
5.5.2 China Gefitinib Market Size and Growth Rate of Drug Center
-
5.5.3 China Gefitinib Market Size and Growth Rate of Other
-
5.5.4 China Gefitinib Market Size and Growth Rate of Clinic
Chapter 6 China Gefitinib Market, by Region
-
6.1 China Gefitinib Production Volume and Production Value, by Region
-
6.2 China Gefitinib Sales Volume and Sales Value, by Region
Chapter 7 North China Gefitinib Market Analysis
-
7.1 North China Gefitinib Market, by Type
-
7.2 North China Gefitinib Market, by Application
Chapter 8 Central China Gefitinib Market Analysis
-
8.1 Central China Gefitinib Market, by Type
-
8.2 Central China Gefitinib Market, by Application
Chapter 9 South China Gefitinib Market Analysis
-
9.1 South China Gefitinib Market, by Type
-
9.2 South China Gefitinib Market, by Application
Chapter 10 East China Gefitinib Market Analysis
-
10.1 East China Gefitinib Market, by Type
-
10.2 East China Gefitinib Market, by Application
Chapter 11 Northeast China Gefitinib Market Analysis
-
11.1 Northeast China Gefitinib Market, by Type
-
11.2 Northeast China Gefitinib Market, by Application
Chapter 12 Southwest China Gefitinib Market Analysis
-
12.1 Southwest China Gefitinib Market, by Type
-
12.2 Southwest China Gefitinib Market, by Application
Chapter 13 Northwest China Gefitinib Market Analysis
-
13.1 Northwest China Gefitinib Market, by Type
-
13.2 Northwest China Gefitinib Market, by Application
Chapter 14 Company Profiles
-
14.1 Nobel Ilac Sanayii Ve Ticaret
-
14.1.1 Nobel Ilac Sanayii Ve Ticaret Company Profile
-
14.1.2 Nobel Ilac Sanayii Ve Ticaret Gefitinib Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Qilu Pharmaceutical
-
14.2.1 Qilu Pharmaceutical Company Profile
-
14.2.2 Qilu Pharmaceutical Gefitinib Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Hetero Drugs
-
14.3.1 Hetero Drugs Company Profile
-
14.3.2 Hetero Drugs Gefitinib Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Celon Laboratories
-
14.4.1 Celon Laboratories Company Profile
-
14.4.2 Celon Laboratories Gefitinib Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Sichuan Xieli Pharmaceutical
-
14.5.1 Sichuan Xieli Pharmaceutical Company Profile
-
14.5.2 Sichuan Xieli Pharmaceutical Gefitinib Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Nishchay Pharmaceuticals
-
14.6.1 Nishchay Pharmaceuticals Company Profile
-
14.6.2 Nishchay Pharmaceuticals Gefitinib Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Jodas Expoim
-
14.7.1 Jodas Expoim Company Profile
-
14.7.2 Jodas Expoim Gefitinib Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Panacea Biotec
-
14.8.1 Panacea Biotec Company Profile
-
14.8.2 Panacea Biotec Gefitinib Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Natco Pharma
-
14.9.1 Natco Pharma Company Profile
-
14.9.2 Natco Pharma Gefitinib Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Dr Reddy’s Laboratories
-
14.10.1 Dr Reddy’s Laboratories Company Profile
-
14.10.2 Dr Reddy’s Laboratories Gefitinib Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Cadila Pharmaceuticals
-
14.11.1 Cadila Pharmaceuticals Company Profile
-
14.11.2 Cadila Pharmaceuticals Gefitinib Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 AstraZeneca
-
14.12.1 AstraZeneca Company Profile
-
14.12.2 AstraZeneca Gefitinib Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 United Biotech
-
14.13.1 United Biotech Company Profile
-
14.13.2 United Biotech Gefitinib Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 Zuventus Healthcare
-
14.14.1 Zuventus Healthcare Company Profile
-
14.14.2 Zuventus Healthcare Gefitinib Market Performance
-
14.14.3 Product&Service Introduction
-
14.15 Cipla
-
14.15.1 Cipla Company Profile
-
14.15.2 Cipla Gefitinib Market Performance
-
14.15.3 Product&Service Introduction
-
14.16 Flagship Biotech International
-
14.16.1 Flagship Biotech International Company Profile
-
14.16.2 Flagship Biotech International Gefitinib Market Performance
-
14.16.3 Product&Service Introduction
-
14.17 Globela Pharma
-
14.17.1 Globela Pharma Company Profile
-
14.17.2 Globela Pharma Gefitinib Market Performance
-
14.17.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Gefitinib Industry Research Conclusions
-
15.2 Gefitinib Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Gefitinib Industry Market Size (2018-2029)
-
Figure China Gefitinib Production Volume, Production Value and Growth Rate of 90 Tables/Box (2018-2029)
-
Figure China Gefitinib Production Volume, Production Value and Growth Rate of 10 Tables/Box (2018-2029)
-
Figure China Gefitinib Production Volume, Production Value and Growth Rate of 30 Tables/Box (2018-2029)
-
Figure China Gefitinib Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
Figure China Gefitinib Sales Volume, Sales Value and Growth Rate of Drug Center (2018-2029)
-
Figure China Gefitinib Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
Figure China Gefitinib Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
Figure North China Gefitinib Market Size and Growth Rate from 2018-2029
-
Figure Central China Gefitinib Market Size and Growth Rate from 2018-2029
-
Figure South China Gefitinib Market Size and Growth Rate from 2018-2029
-
Figure East China Gefitinib Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Gefitinib Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Gefitinib Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Gefitinib Market Size and Growth Rate from 2018-2029
-
Figure Gefitinib Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Gefitinib Market Share by Type in 2018
-
Figure China Gefitinib Market Share by Type in 2023
-
Figure China Gefitinib Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Gefitinib Production Volume and Growth Rate of 90 Tables/Box (2018-2023)
-
Figure China Gefitinib Production Volume and Growth Rate of 10 Tables/Box (2018-2023)
-
Figure China Gefitinib Production Volume and Growth Rate of 30 Tables/Box (2018-2023)
-
Figure China Gefitinib Market Share by Application in 2018
-
Figure China Gefitinib Market Share by Application in 2023
-
Figure China Gefitinib Total Market Size and Growth Rate from Consumption End
-
Figure China Gefitinib Market Size and Growth Rate of Hospital (2018-2023)
-
Figure China Gefitinib Market Size and Growth Rate of Drug Center (2018-2023)
-
Figure China Gefitinib Market Size and Growth Rate of Other (2018-2023)
-
Figure China Gefitinib Market Size and Growth Rate of Clinic (2018-2023)
-
Table China Gefitinib Production Volume by Region (2018-2023)
-
Table China Gefitinib Production Volume Share by Region (2018-2023)
-
Figure China Gefitinib Production Volume Share by Region (2018-2023)
-
Table China Gefitinib Production Value by Region (2018-2023)
-
Table China Gefitinib Production Value Share by Region (2018-2023)
-
Figure China Gefitinib Production Value Share by Region (2018-2023)
-
Table China Gefitinib Sales Volume by Region (2018-2023)
-
Table China Gefitinib Sales Volume Share by Region (2018-2023)
-
Figure China Gefitinib Sales Volume Share by Region (2018-2023)
-
Table China Gefitinib Sales Value by Region (2018-2023)
-
Table China Gefitinib Sales Value Share by Region (2018-2023)
-
Figure China Gefitinib Sales Value Share by Region (2018-2023)
-
Table North China Gefitinib Production Volume by Type (2018-2023)
-
Table North China Gefitinib Production Volume Share by Type (2018-2023)
-
Figure North China Gefitinib Production Volume Share by Type (2018-2023)
-
Table North China Gefitinib Sales Volume by Application (2018-2023)
-
Table North China Gefitinib Sales Volume Share by Application (2018-2023)
-
Figure North China Gefitinib Sales Volume Share by Application (2018-2023)
-
Table Central China Gefitinib Production Volume by Type (2018-2023)
-
Table Central China Gefitinib Production Volume Share by Type (2018-2023)
-
Figure Central China Gefitinib Production Volume Share by Type (2018-2023)
-
Table Central China Gefitinib Sales Volume by Application (2018-2023)
-
Table Central China Gefitinib Sales Volume Share by Application (2018-2023)
-
Figure Central China Gefitinib Sales Volume Share by Application (2018-2023)
-
Table South China Gefitinib Production Volume by Type (2018-2023)
-
Table South China Gefitinib Production Volume Share by Type (2018-2023)
-
Figure South China Gefitinib Production Volume Share by Type (2018-2023)
-
Table South China Gefitinib Sales Volume by Application (2018-2023)
-
Table South China Gefitinib Sales Volume Share by Application (2018-2023)
-
Figure South China Gefitinib Sales Volume Share by Application (2018-2023)
-
Table East China Gefitinib Production Volume by Type (2018-2023)
-
Table East China Gefitinib Production Volume Share by Type (2018-2023)
-
Figure East China Gefitinib Production Volume Share by Type (2018-2023)
-
Table East China Gefitinib Sales Volume by Application (2018-2023)
-
Table East China Gefitinib Sales Volume Share by Application (2018-2023)
-
Figure East China Gefitinib Sales Volume Share by Application (2018-2023)
-
Table Northeast China Gefitinib Production Volume by Type (2018-2023)
-
Table Northeast China Gefitinib Production Volume Share by Type (2018-2023)
-
Figure Northeast China Gefitinib Production Volume Share by Type (2018-2023)
-
Table Northeast China Gefitinib Sales Volume by Application (2018-2023)
-
Table Northeast China Gefitinib Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Gefitinib Sales Volume Share by Application (2018-2023)
-
Table Southwest China Gefitinib Production Volume by Type (2018-2023)
-
Table Southwest China Gefitinib Production Volume Share by Type (2018-2023)
-
Figure Southwest China Gefitinib Production Volume Share by Type (2018-2023)
-
Table Southwest China Gefitinib Sales Volume by Application (2018-2023)
-
Table Southwest China Gefitinib Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Gefitinib Sales Volume Share by Application (2018-2023)
-
Table Northwest China Gefitinib Production Volume by Type (2018-2023)
-
Table Northwest China Gefitinib Production Volume Share by Type (2018-2023)
-
Figure Northwest China Gefitinib Production Volume Share by Type (2018-2023)
-
Table Northwest China Gefitinib Sales Volume by Application (2018-2023)
-
Table Northwest China Gefitinib Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Gefitinib Sales Volume Share by Application (2018-2023)
-
Table Nobel Ilac Sanayii Ve Ticaret Company Profile
-
Table Nobel Ilac Sanayii Ve Ticaret Gefitinib Revenue, Price and Gross (2018-2023)
-
Table Qilu Pharmaceutical Company Profile
-
Table Qilu Pharmaceutical Gefitinib Revenue, Price and Gross (2018-2023)
-
Table Hetero Drugs Company Profile
-
Table Hetero Drugs Gefitinib Revenue, Price and Gross (2018-2023)
-
Table Celon Laboratories Company Profile
-
Table Celon Laboratories Gefitinib Revenue, Price and Gross (2018-2023)
-
Table Sichuan Xieli Pharmaceutical Company Profile
-
Table Sichuan Xieli Pharmaceutical Gefitinib Revenue, Price and Gross (2018-2023)
-
Table Nishchay Pharmaceuticals Company Profile
-
Table Nishchay Pharmaceuticals Gefitinib Revenue, Price and Gross (2018-2023)
-
Table Jodas Expoim Company Profile
-
Table Jodas Expoim Gefitinib Revenue, Price and Gross (2018-2023)
-
Table Panacea Biotec Company Profile
-
Table Panacea Biotec Gefitinib Revenue, Price and Gross (2018-2023)
-
Table Natco Pharma Company Profile
-
Table Natco Pharma Gefitinib Revenue, Price and Gross (2018-2023)
-
Table Dr Reddy’s Laboratories Company Profile
-
Table Dr Reddy’s Laboratories Gefitinib Revenue, Price and Gross (2018-2023)
-
Table Cadila Pharmaceuticals Company Profile
-
Table Cadila Pharmaceuticals Gefitinib Revenue, Price and Gross (2018-2023)
-
Table AstraZeneca Company Profile
-
Table AstraZeneca Gefitinib Revenue, Price and Gross (2018-2023)
-
Table United Biotech Company Profile
-
Table United Biotech Gefitinib Revenue, Price and Gross (2018-2023)
-
Table Zuventus Healthcare Company Profile
-
Table Zuventus Healthcare Gefitinib Revenue, Price and Gross (2018-2023)
-
Table Cipla Company Profile
-
Table Cipla Gefitinib Revenue, Price and Gross (2018-2023)
-
Table Flagship Biotech International Company Profile
-
Table Flagship Biotech International Gefitinib Revenue, Price and Gross (2018-2023)
-
Table Globela Pharma Company Profile
-
Table Globela Pharma Gefitinib Revenue, Price and Gross (2018-2023)
-
